Maria Beroendecentrum AB has been acquired by Capio AB
Maria Beroendecentrum AB, healthcare provider operating a drying-out clinic, has been acquired by Capio AB. Financial details have not been disclosed.
Capio has won the procurement to operate addiction treatment care within the county council of Stockholm for the next five years. After this acquisition, the new company will have almost 200 employees.
“We are very happy with the notification from the city council of Stockholm (SLL) implying that we will operate and manage the important addiction treatment program within the region of Stockholm. With locally integrated care centers within close reach of the patients, we will do our best to efficiently help and cure patients with drug and addiction habits,” said Åke Strandberg, Business Area Manager of Specialist Clinics Operations in Sweden.
Oaklins' team in Sweden advised the seller in this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Lär dig merbioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Lär dig merBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Lär dig mer